CGEN
CompugenBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
+
Peers tracked
10
U.S. public peers
Grade Position
Above peers
vs peer average
CGEN vs peer average
82/100
CGEN vs. peer average (B vs. D)
Grade spread
A 1 · D 6 · F 3
Graded peers loaded
Coverage
10 graded
100% of tracked
Peer overview
ANTX is the first available peer comparator.
Same-sector, similar-market-cap candidate; useful only for framing small-cap clinical-biotech event risk, with direct operating comparability unverified.
✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
CGEN
Compugen
ANTX
AN2 Therapeutics
Grade
B
D
Momentum
89
94
Value
56
41
Sentiment
67
38
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Grade position vs ANTX
CGEN / ANTX
Grade Position
Above peers
CGEN vs. peer average (B vs. D)
82/100
Momentum
89
ANTXValue
56
CGENSentiment
67
CGENRotation landscape
Peers ranked by the order returned from the peer source, with grades from the API.
Rank
Ticker
Company
Grade
Grade score
vs CGEN
ANTX is the first peer returned for this comparison set.